Tardive Dyskinesia Treatment Market: By Drug Class (Beta Blockers, Vitamin E Systemic, VMAT2 Inhibitors, Dopaminergic Agents, Benzodiazepines), By Disorder (Bradykinesia, Hyperkinesia), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Tardive Dyskinesia Treatment Market size was valued at USD 5.68 billion in 2023 and is poised to grow at a CAGR of 4.2% from 2024-2030. Tardive dyskinesia is a neurological condition in which involuntary movements are involved. The phrases tardive and dyskinesia can be defined as delayed and aberrant movement, respectively. Finger movement, facial grimacing, jaw swinging, repetitive chewing, constant blinking of the eyes, tongue pushing, and other symptoms of tardive dyskinesia. Tardive dyskinesia is a side effect of neurotic medications. These drugs are also known as anti-psychotics or strong tranquilizers. These medications are mostly used to treat mental illnesses. When you use a drug for months or years, you may develop tardive dyskinesia. Because the drug that can be used to treat tardive dyskinesia has not yet been licensed, and the method of treatment has not yet been validated, treating the disease is a challenging undertaking. The patient's neurological system is affected by the tardive dyskinesia treatment. Because the drug that can be used to treat tardive dyskinesia has not yet been licensed, and the method of treatment has not yet been validated, treating the disease is a challenging undertaking. The patient's neurological system is affected by the tardive dyskinesia treatment.  

Global Tardive Dyskinesia Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.2%

Largest Market

North-America

Fastest Growing Market

North America
Tardive Dyskinesia Treatment Market Dynamics

In the approaching years, the market for tardive dyskinesia treatment will expand dramatically. The increasing number of people suffering from neurological problems is a major element driving the tardive dyskinesia therapy market. The majority of the population in North America suffers from tardive dyskinesia, and individuals are eagerly anticipating treatment, driving the market's growth. The approval process for new treatment modalities by the respective association is a stumbling block to market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Tardive Dyskinesia Treatment Market Segmentation

By Drug Class
  • Beta blockers
  • Vitamin E systemic
  • VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors)
  • Dopaminergic agents
  • Benzodiazepines
By Disorder
  • Bradykinesia
  • Hyperkinesia
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Frequently Asked Questions

The tardive dyskinesia treatment market size was valued at USD 5.68 billion in 2023

Biogen (U.S) Teva Pharmaceutical Industries Ltd. (Israel) GlaxoSmithKline Plc.(U.K) Johnson & Johnson Services, Inc.(U.S) Pfizer Inc.(U.S) Neurocrine Biosciences, Inc.(U.S)

The tardive dyskinesia treatment market segments are by drug classes, disorder, and distribution channel

  1. Executive Summary
  2. Global Tardive Dyskinesia Treatment Market Introduction
    • Global Tardive Dyskinesia Treatment Market – Taxonomy
    • Global Tardive Dyskinesia Treatment Market – Definitions
      • Drug Class
      • Route of Administration
      • Distribution Channel
  1. Global Tardive Dyskinesia Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Tardive Dyskinesia Treatment Market Dynamic Factors - Impact Analysis
    • Global Tardive Dyskinesia Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Tardive Dyskinesia Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
    • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Tardive Dyskinesia Treatment Market, By Drug Class, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Beta blockers
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Vitamin E systemic
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors)
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Dopaminergic agents
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Benzodiazepines
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Tardive Dyskinesia Treatment Market Forecast, By Route of Administration, 2019 - 2023 and Forecast, 2024 - 2030
    • Oral
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Tardive Dyskinesia Treatment Market Forecast, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Tardive Dyskinesia Treatment Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Tardive Dyskinesia Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Region, 2024 - 2030
  2. North America Tardive Dyskinesia Treatment MarketAnalysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Beta blockers
      • Vitamin E systemic
      • VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors)
      • Dopaminergic agents
      • Benzodiazepines
    • Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2016 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Tardive Dyskinesia Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country, 2024 - 2030
    • North America Tardive Dyskinesia Treatment Market Dynamics – Trends
  3. Europe Tardive Dyskinesia Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Beta blockers
      • Vitamin E systemic
      • VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors)
      • Dopaminergic agents
      • Benzodiazepines
    • Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Tardive Dyskinesia Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country, 2024 - 2030
    • Europe Tardive Dyskinesia Treatment Market Dynamics – Trends
  4. Asia-Pacific Tardive Dyskinesia Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Beta blockers
      • Vitamin E systemic
      • VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors)
      • Dopaminergic agents
      • Benzodiazepines
    • Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Tardive Dyskinesia Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country, 2024 - 2030
    • Asia-PacificTardive Dyskinesia Treatment Market Dynamics – Trends
  5. Latin America Tardive Dyskinesia Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Beta blockers
      • Vitamin E systemic
      • VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors)
      • Dopaminergic agents
      • Benzodiazepines
    • Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Tardive Dyskinesia Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country, 2024 - 2030
    • Latin America Tardive Dyskinesia Treatment Market Dynamics – Trends
  6. Middle East and Africa Tardive Dyskinesia Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
    • Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Beta blockers
      • Vitamin E systemic
      • VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors)
      • Dopaminergic agents
      • Benzodiazepines
    • Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Tardive Dyskinesia Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country, 2024 - 2030
    • MEA Tardive Dyskinesia Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Biogen (U.S)
      • Teva Pharmaceutical Industries Ltd. (Israel)
      • GlaxoSmithKline Plc.(U.K)
      • Johnson & Johnson Services, Inc.(U.S)
      • Pfizer Inc.(U.S)
      • Neurocrine Biosciences, Inc.(U.S)
      • Novartis AG(Switzerland)
      • AstraZeneca (U.K)
      • Bayer AG (Germany)
      • Sanofi (France)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Biogen (U.S)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • GlaxoSmithKline Plc.(U.K)
  • Johnson & Johnson Services, Inc.(U.S)
  • Pfizer Inc.(U.S)
  • Neurocrine Biosciences, Inc.(U.S)
  • Novartis AG (Switzerland)
  • AstraZeneca (U.K)
  • Bayer AG (Germany)
  • Sanofi (France)

Adjacent Markets

Eosinophilia Market
Dyspepsia Market
Disseminated Intravascular Coagulation Market
Alpha Thalassemia Market
Allergic Rhinitis Market
Histamine Analogs Market